Myasthenic Crisis - Comorbidities, Complications, Long-Term Outcomes: The Challenges
- PMID: 31736572
- PMCID: PMC6839328
- DOI: 10.4103/aian.AIAN_472_19
Myasthenic Crisis - Comorbidities, Complications, Long-Term Outcomes: The Challenges
Conflict of interest statement
There are no conflicts of interest.
References
-
- Gilhus NE, Verschuuren JJ. Myasthenia gravis: Subgroup classification and therapeutic strategies. Lancet Neurol. 2015;14:1023–36. - PubMed
-
- Bedlack RS, Sanders DB. On the concept of myasthenic crisis. J Clin Neuromuscul Dis. 2002;4:40–2. - PubMed
-
- Murthy JMK, Meena AK, Chowdary GVS, Naraynan JT. Myasthenic crisis: Clinical features. Complications and mortality. Neurol India. 2005;53:36–40. - PubMed
-
- Alshekhlee A, Miles JD, Katirij B, Preston DC, Kaminski HJ. Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospital. Neurology. 2009;72:1548–54. - PubMed